Biodegradable materials, including natural and synthetic polymers and hydrolyzable metals,
constitute the main components of temporary, implantable medical devices. Besides the …

Magnesium (Mg) and its alloys, as potential biodegradable materials, have drawn wide
attention in the cardiovascular stent field because of their appropriate mechanical properties …

Background Bioresorbable vascular scaffolds were developed to overcome the
shortcomings of drug-eluting stents in percutaneous coronary intervention (PCI). We …

Background Despite rapid dissemination of an everolimus-eluting bioresorbable scaffold for
treatment for coronary artery disease, no data from comparisons with its metallic stent …

Background Recent reports suggest an elevated incidence of bioresorbable vascular
scaffold (BVS) thrombosis (scaffold thrombosis [ScT]). Objectives This study investigated …

Fully bioresorbable scaffolds (BRS) were designed to overcome the limitations of metallic
drug-eluting stents, which permanently cage the vessel wall, thereby preventing normal …

Compared to bare-metal stents (BMSs), drug-eluting stents (DESs) have been regarded as a
revolutionary change in coronary artery diseases (CADs). Releasing pharmaceutical agents …

Background In patients with coronary artery disease who receive metallic drug-eluting
coronary stents, adverse events such as late target-lesion failure may be related in part to …

Background Compared with metallic drug-eluting stents, bioresorbable vascular scaffolds
(BVS) offer the potential to improve long-term outcomes of percutaneous coronary …

Current generation of drug-eluting stents has significantly improved the outcomes of
percutaneous coronary intervention by substantially reducing in-stent restenosis and stent …